U.S. Renal Care competitors

Joseph 'Joe' Carlucci is a Board Member at Colorado Cntr Reproductive Med, CEO/Co-Founder at American Renal Holdings Inc, and Board Member at American Renal Holdings Inc. He has worked as Chairman/CEO/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.; COO/Treasurer/Co-Founder at American Renal Holdings Inc; and COO/Treasurer/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.. Joseph works or has worked as President/CEO at Optimal Renal Care. He studied at Bentley University.

Mr. Rodriguez joined our Board in June 2020. Since 2019, Mr. Rodriguez has been the Chief Executive Officer of DaVita Inc., a Fortune 500 company providing healthcare services to kidney disease patients throughout the United States and internationally. DaVita strives to improve patients’ quality of life through clinical innovation and integrated, personalized care. From 2014 to 2019, he was the CEO of DaVita Kidney Care, the company’s business unit that treats patients with kidney failure and end-stage renal disease. Mr. Rodriguez has spent more than 20 years in various executive roles at DaVita, driving the company’s transformation for how kidney care is delivered. In 2019, Mr. Rodriguez was ranked No. 40 on the Modern Healthcare list of 100 Most Influential People in Healthcare and in 2015 was named one of the Top 10 Leaders by Hispanic Executive magazine. He currently serves as a member of the boards of directors of DaVita and the Denver Metro Chamber of Commerce.

William Valle leads the globally operating Care Delivery segment, in which the company is combining its global healthcare services business effective January 1, 2022. Previously, he served as Chief Executive Officer for North America since February 17, 2017. Prior to that, he was Executive Vice President responsible for the dialysis service business and vascular access business of Fresenius Medical Care North America from 2014 to 2017. Bill joined Fresenius Medical Care in 2009 and has more than 30 years of experience in the dialysis industry, holding executive positions in sales, marketing and business development at several dialysis companies including Gambro Healthcare, Inc.

John Langlois is a Chief Executive Officer at Riverview Regional Medical Center. He has worked as Chief Financial Officer at Riverview Regional Medical Center, Interim President/CFO at Walker Baptist Medical Center, and Chief Executive Officer at Walker Baptist Medical Center. John works or has worked as Chief Financial Officer at Citizens Baptist Medical Cente. He attended University of Memphis.

Jeffrey Goffman is the CEO of Satellite Healthcare a National leading Kidney care company dedicated to making life better for those living with Kidney disease. Satellite has more than 85 locations across 5 states and provides in-center & home dialysis, a CVS Kidney partnership, clinical research & CKD care management focused on improving the quality and access to home dialysis care, reducing costs and implementing integrated value-based care. Goffman is the Vice Chairman of OneGI a Webster Equity portfolio company that is a gastroenterology management services organization that partners with GI physicians to help them manage, optimize & grow their practices and focus on providing excellent care to their patients. Goffman was the CEO of Integrated Oncology Network, LLC (“ION”) which he co-founded in 2008 until 2019. ION is a national oncology company that provides management services to its physician and hospital partners. ION owns more than 50 oncology centers across 17 states in partnership with approximately 300 physicians and 20 hospitals including some of the most prestigious healthcare systems in the US. Goffman was the CEO and Founder of OnCURE Medical Corp. (“OnCURE”) from its inception in 1998 until 2006 when it was sold. OnCURE was private equity sponsored and one of the largest providers of outpatient radiation oncology care in the United States with 40 centers owned and managed and affiliated with more than 100 physicians. Goffman was the CEO of U.S. Diagnostic, Inc. (“USD”), a leading consolidator of diagnostic imaging facilities. Goffman took USD public in 1994, and from inception until 1997 Goffman grew USD to 120 centers inGoffman is an inactive licensed Certified Public Accountant, member of the American Institute of Certified Public Accountants, and holds a Bachelor of Science degree in Accounting from the Barney School of Business at the University of Hartford. Goffman was inducted into the Barney School of Business Alumni Hall of Fame in 2014. Goffman is a member of the board of directors of several non-profit organizations including the American Cancer Society’s CEO’s Against Cancer and CureDuchenne.